Research Article
[Retracted] Impact of HSP90α, CEA, NSE, SCC, and CYFRA21-1 on Lung Cancer Patients
Table 1
Correlation between plasma HSP90α concentration and various clinical pathological parameters of lung cancer.
| Pathological feature | Number of cases | HSP90α (ng/ml) | |
| Male | 53 | 89.77 ± 55.03 | 0.2 | Female | 25 | 99.69 ± 63.76 | 0.2 | Age ≥ 65 | 39 | 84.57 ± 58.52 | 0.4 | Age < 65 | 39 | 101.32 ± 56.46 | 0.4 | Smoking—yes | 41 | 86.61 ± 51.75 | 0.88 | Smoking—no | 37 | 84.77 ± 54.31 | 0.88 | Left side | 34 | 93.95 ± 67.03 | 0.8 | Right side | 44 | 92.17 ± 50.21 | 0.89 | Adenocarcinoma | 45 | 85.03 ± 47.87 | 0.5 | Small cell | 10 | 147.67 ± 47.00 | 0.4 | Squamous carcinoma | 22 | 78.27 ± 53.64 | 0.6 | Giant cell | 1 | 225.39 | 0.621 | Degree of differentiation (DoD) | High DoD | 17 | 67.90 ± 37.57 | 0.608 | Moderate DoD | 22 | 81.28 ± 47.49 | 0.624 | Poor DoD | 28 | 90.06 ± 55.37 | 0.689 | Undifferentiated | 11 | 154.74 ± 67.74 | 0.749 | 1. | 26 | 64.98 ± 38.67 | 0.7 | 2. | 8 | 64.91 ± 15.87 | 0.68 | 3. | 18 | 89.15 ± 47.92 | 0.6 | 4. | 26 | 132.18 ± 66.82 | 0.6 | Lung metastasis—yes | 11 | 113.75 ± 69.92 | 0.04 | Lung metastasis—no | 62 | 80.65 ± 49.34 | 0.04 | Lymph node metastasis (LNM)—yes | 44 | 89.52 ± 48.38 | 0.081 | LNM—no | 35 | 81.26 ± 57.67 | 0.081 | Bone metastasis (BM)—yes | 14 | 111.38 ± 51.02 | 0.01 | BM—no | 65 | 81.37 ± 52.07 | 0.01 |
|
|